Anterogen.Co.,Ltd. (KOSDAQ:065660)
South Korea · Delayed Price · Currency is KRW 39,100
-1,000 (-2.49%)
At close: Feb 6, 2026
Anterogen.Co.,Ltd. Market Cap
Anterogen.Co.,Ltd. has a market cap or net worth of 391.24 billion as of February 6, 2026. Its market cap has increased by 105.12% in one year.
Market Cap
391.24B
Enterprise Value
347.15B
Revenue
7.32B
Ranking
n/a
PE Ratio
n/a
Stock Price
39,100.00
Market Cap Chart
Since February 15, 2016, Anterogen.Co.,Ltd.'s market cap has increased from 291.82B to 391.24B, an increase of 34.07%. That is a compound annual growth rate of 2.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 391.24B | -16.54% |
| Dec 30, 2025 | 468.79B | 155.02% |
| Dec 30, 2024 | 183.83B | 10.53% |
| Dec 28, 2023 | 166.31B | 16.26% |
| Dec 29, 2022 | 143.05B | -76.39% |
| Dec 30, 2021 | 605.82B | 6.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Feb 15, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Onconic Therapeutics | 743.34B |
| Green Cross Holdings | 677.39B |
| Genomictree | 544.78B |
| SillaJen | 516.61B |
| BINEX | 454.78B |
| JETEMA, | 348.91B |
| Bioneer | 325.98B |
| Helixmith | 279.04B |